Skip to main content

C9306 HCPCS Level II Code: Injection, telisotuzumab vedotin-tllv, 1 mg

Medicare Coverage & Payment

  • CMS short descriptor: Telisotuzumab vedotin-tllv
  • Medicare coverage: Special coverage instructions apply (CMS coverage code D)
  • Pricing indicator: 53
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2026
  • Terminated: December 31, 2025

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Code Set: Removed from the code set — not valid on or after January 1, 2026.

Contextual Map

Every relationship of C9306 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (24)

Change history (2)

  • January 1, 2026 — Removed from the code set [Change history]
  • and 1 more

Sources for this page

Every coding fact on this page is read from the datasets below. Nothing is AI-generated; MedCoder-derived relationships and editorial are labelled where they appear.

Code, descriptors, coverage and pricing attributes
CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update
Change history and date-of-service validity
CMS HCPCS quarterly update files, ingested into the change ledger
Comparisons, relationships and the contextual map MedCoder-derived
Derived by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears

All data sources and release dates

Change history

  • January 1, 2026
    Removed from the code set
    Injection, telisotuzumab vedotin-tllv, 1 mg
  • October 1, 2025
    Added to the code set
    Injection, telisotuzumab vedotin-tllv, 1 mg

Nearest Codes in This Family

Official HCPCS Level II classifications closest to C9306 in its code family, with their registry titles.